Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Laboratory monitoring of high-dose factor VIIa therapy.

    Hoffman M.

    Ann Intern Med. 2003 Nov 4;139(9):791. No abstract available. PMID: 14597470 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. A new way to reverse excessive blood thinning from warfarin.

    [No authors listed]

    Ann Intern Med. 2002 Dec 3;137(11):I41. No abstract available. PMID: 12459002 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Antidotes to haemorrhage: recombinant factor VIIa.

    Kessler CM.

    Best Pract Res Clin Haematol. 2004 Mar;17(1):183-97. Review.PMID: 15171966 [PubMed - indexed for MEDLINE]Related articles

    4.

    Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature.

    Da'as N, Misgav M, Kalish Y, Varon D.

    Isr Med Assoc J. 2006 Nov;8(11):807-11. Review. No abstract available. PMID: 17180836 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    rFVIIa (Novoseven): the new panacea?

    Ickx BE.

    Acta Anaesthesiol Belg. 2003;54(4):333-5. No abstract available. PMID: 14719355 [PubMed - indexed for MEDLINE]Related articles

    6.

    Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.

    Malherbe S, Tsui BC, Stobart K, Koller J.

    Anesthesiology. 2004 Feb;100(2):443-5. No abstract available. PMID: 14739823 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Is recombinant FVIIa the magic bullet in the treatment of major bleeding?

    Spahn DR, Tucci MA, Makris M.

    Br J Anaesth. 2005 May;94(5):553-5. No abstract available. PMID: 15814804 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Treatment of critical bleeding in the future intensive care unit.

    Goodnough LT.

    Intensive Care Med. 2002 Oct;28 Suppl 2:S221. No abstract available. PMID: 12583409 [PubMed - indexed for MEDLINE]Related articles

    9.

    Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors.

    Hedner U.

    J Thromb Haemost. 2006 Nov;4(11):2498-500. Epub 2006 Aug 14. Review. No abstract available. PMID: 16907841 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recombinant factor VIIa as an antidote for anticoagulant treatment.

    Levi M, Bijsterveld NR, Keller TT.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):65-9. Review.PMID: 14872424 [PubMed - indexed for MEDLINE]Related articles

    11.

    A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy.

    Smaradottir A, Bona R.

    Thromb Haemost. 2004 Sep;92(3):666-7. No abstract available. Erratum in: Thromb Haemost. 2005 May;93(5):1009. Dosage error in article text. PMID: 15457604 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

    Grounds RM, Bolan C.

    Crit Care. 2005;9 Suppl 5:S29-36. Epub 2005 Oct 7. Review. Erratum in: Crit Care. 2005;9(6):560. PMID: 16221317 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

    Baudo F, de Cataldo F, Gaidano G; Italian registry of acquired hemophilia.

    Haematologica. 2004 Jun;89(6):759-61.PMID: 15194550 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    NovoSeven for non-hemophilia hemostasis.

    [No authors listed]

    Med Lett Drugs Ther. 2004 Apr 26;46(1181):33-4. No abstract available. PMID: 15114252 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recombinant factor VIIa: a review on its clinical use.

    Franchini M.

    Int J Hematol. 2006 Feb;83(2):126-38. Review.PMID: 16513530 [PubMed - indexed for MEDLINE]Related articles

    16.

    Monitoring coagulation and the clinical effects of recombinant factor VIIa.

    Gabriel DA, Carr M, Roberts HR.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):20-4. Review.PMID: 14872416 [PubMed - indexed for MEDLINE]Related articles

    17.

    Views on methods for monitoring recombinant factor VIIa in inhibitor patients.

    Key NS, Nelsestuen GL.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):51-4. Review.PMID: 14872422 [PubMed - indexed for MEDLINE]Related articles

    18.

    Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.

    Bauzá G, Hirsch E, Burke P, Quillen K.

    Transfusion. 2007 Apr;47(4):749-51. No abstract available. PMID: 17381636 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review.

    Trowbridge CC, Stammers AH, Ciccarelli N, Klayman M.

    J Extra Corpor Technol. 2006 Sep;38(3):254-9. Review.PMID: 17089513 [PubMed - indexed for MEDLINE]Related articles

    20.

    Current and future challenges of antithrombotic agents and anticoagulants: Strategies for reversal of hemorrhagic complications.

    Kessler CM.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):44-50. Review.PMID: 14872421 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data